An in vitro short time-high dose drug exposure assay for predicting 5FU-resistance of colorectal cancer

Cancer Letters

Volumn 214, Issue 2, 2004, Pages 181-188

  Fan, Chung Wei ^a   Fan, Hong Arh ^a   Hsu, Soon Hwei ^c   Chan, Chang Chuan ^b   Chen, Shih Yuan ^c   Hsu, Yuan Hsun ^d   Chan, Err Cheng ^c  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CATHAY GENERAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

5 Fluorouracil; ATP assay; Chemotherapy; Extreme drug resistance

Indexed keywords

FLUOROURACIL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER CELL; CANCER STAGING; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL ISOLATION; CELL SURVIVAL; CELL VIABILITY; COLORECTAL CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; ENZYMATIC ASSAY; FEMALE; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE;

ADENOSINE TRIPHOSPHATE; ANTIMETABOLITES, ANTINEOPLASTIC; BIOLOGICAL ASSAY; CELL SURVIVAL; COLORECTAL NEOPLASMS; DRUG RESISTANCE, NEOPLASM; FLUOROURACIL; FORECASTING; HUMANS; PREDICTIVE VALUE OF TESTS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 4444312090     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.06.004     Document Type: Article

References (21)

1. R. Gorlick, and J.R. Bertino Drug resistance in colon cancer Semin. Oncol. 26 1999 606 611
2. H.J. Schmoll, T. Buchele, A. Grothey, and W. Dempke Where do we stand with 5-fluorouracil? Semin. Oncol. 26 1999 589 605
3. W.A. Hamburger, and S.E. Salmon Primary bioassay of human tumor stem cells Science 197 1997 461 463
4. 3H) thymidine incorporation in a modified human tumor stem cell assay Cancer Res. 42 1982 4683 4689
5. B.U. Sevin, Z.L. Peng, J.P. Perras, P. Ganjei, M. Penalver, and H.E. Averette Application of an ATP-bioluminescence assay in human tumor chemosensitivity testing Gynecol. Oncol. 31 1988 191 204
6. H. Yamaue, H. Tanimura, M. Nakamori, K. Noguchi, M. Iwahashi, M. Tani, T. Hotta, K. Murakami, and K. Ishimoto Clinical evaluation of chemosensitivity testing for patients with colorectal cancer using MTT assay Dis. Colon. Rectum 39 1996 416 422
7. L.M. Weisenthal, J.A. Marsden, P.L. Dill, and C.K. Macaluso A novel dye exclusion method for testing in vitro chemosensitivity of human tumors Cancer Res. 43 1983 749 757
8. P.E. Andreotti, I.A. Cree, C.M. Kurbacher, D.M. Hartmann, D. Linder, G. Havel, I. Gleiberman, P.A. Caruso, S.H. Ricks, and M. Untch Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma Cancer Res. 55 1995 5276 5282
9. L. Mollgard, U. Tidefelt, B. Sundman-Engberg, C. Lofgren, and C. Paul In vitro chemosensitivity testing in acute nonlymphocytic leukemia using the bioluminescence ATP assay Leukemia Res. 24 2000 445 452
10. S.P. Crouch, R. Kozlowski, K.J. Slater, and J. Fletcher The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity J. Immunol. Methods 160 1993 81 88
11. E. Petru, B.U. Sevin, J. Perras, G. Boike, R. Ramos, H. Nguyen, and H.E. Averette Comparative chemosensitivity profiles in four human ovarian carcinoma cell lines measuring ATP bioluminescence Gynecol. Oncol. 38 1990 155 160
12. A.T. O'Meara, and B.U. Sevin Predictive value of the ATP chemosensitivity assay in epithelial ovarian cancer Gynecol. Oncol. 83 2001 334
13. I.A. Cree, and C.M. Kurbacher ATP-based tumor chemosensitivity testing: assisting new agent development Anticancer Drugs 10 1999 431 435
14. S.K. Khoo, T. Hurst, J. Lark, M.J. Webb, P. Parsons, and E.V. Mackay In vitro sensitivity of ovarian cancer as determined by a short-term biochemical assay: comparison between primary and metastatic site in the same patient Gynecol. Oncol. 32 1989 151 155
15. D.H. Kern, and L.M. Weisenthal Highly specific prediction of antineoplastic drug resistance with an in vitro assay using suprapharmacologic drug exposures J. Natl Cancer Inst. 82 1990 582 588
16. E. Browm, and M. Markman Tumor chemosensitivity and chemoresistance assays Am. Cancer Soc. 77 1996 1020 1025
17. G. Agiostratidou, I. Sgouros, E. Galani, A. Voulgari, N. Chondrogianni, E. Samantas, and Dimopoulos Correlation of in vitro cytotoxicity and clinical response to chemotherapy in ovarian and breast cancer patients Anticancer Res. 21 2001 455 460
18. C. Aschele, A. Sobrero, M.A. Faderan, and J.R. Bertino Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedules Cancer Res. 52 1992 1855 1864
19. A. Harstrick, A. Gonzales, N. Schleucher, U. Vanhoefer, K. Lu, J.L. Formento, G. Milano, and H. Wilke Comparison between short or long exposure to 5-fluorouracil in human gastric and colon cancer cell lines: biochemical mechanism of resistance Anticancer Drugs 9 1998 625 634
20. V. Fernandez-Trigo, F. Shamsa, J. Vidal-Jove, D.H. Kern, and P.H. Sugarbaker Prognostic implications of chemoresistance-sensitivity assays for colorectal and appendiceal cancer Am. J. Clin. Oncol. 18 1995 454 460
21. H. Yamaue, H. Tanimura, M. Nakamori, M. Iwahashi, M. Tani, T. Hotta, and K. Murakami Clinical evaluation of chemosensitivity testing for patients with colorectal cancer using MTT assay Dis. Colon Rectum 39 1996 16 422